169 related articles for article (PubMed ID: 29732516)
1. Survival analysis of patients with spinal chordomas.
Sun HH; Hong X; Liu B; Cui JQ; Zhou ZM; Xie XH; Wu XT
Neurosurg Rev; 2019 Jun; 42(2):455-462. PubMed ID: 29732516
[TBL] [Abstract][Full Text] [Related]
2. Analysis of prognostic factors for survival in patients with primary spinal chordoma using the SEER Registry from 1973 to 2014.
Pan Y; Lu L; Chen J; Zhong Y; Dai Z
J Orthop Surg Res; 2018 Apr; 13(1):76. PubMed ID: 29625617
[TBL] [Abstract][Full Text] [Related]
3. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
[TBL] [Abstract][Full Text] [Related]
4. Nomogram for Individualized Prediction and Prognostic Factors for Survival in Patients with Primary Spinal Chordoma: A Population-Based Longitudinal Cohort Study.
Huang JF; Chen D; Sang CM; Zheng XQ; Lin JL; Lin Y; Ni WF; Wang XY; Li YM; Wu AM
World Neurosurg; 2019 Aug; 128():e603-e614. PubMed ID: 31054340
[TBL] [Abstract][Full Text] [Related]
5. Expression of ezrin, MMP-9, and COX-2 in 50 chordoma specimens: a clinical and immunohistochemical analysis.
Froehlich EV; Scheipl S; Lazàry A; Varga PP; Schmid C; Stammberger H; Beham A; Bodo K; Schroettner H; Quehenberger F; Windhager R; Liegl B; Leithner A
Spine (Phila Pa 1976); 2012 Jun; 37(13):E757-67. PubMed ID: 22228328
[TBL] [Abstract][Full Text] [Related]
6. Chordomas of the Skull Base, Mobile Spine, and Sacrum: An Epidemiologic Investigation of Presentation, Treatment, and Survival.
Zuckerman SL; Bilsky MH; Laufer I
World Neurosurg; 2018 May; 113():e618-e627. PubMed ID: 29486315
[TBL] [Abstract][Full Text] [Related]
7. Mobile spine chordoma: results of 166 patients from the AOSpine Knowledge Forum Tumor database.
Gokaslan ZL; Zadnik PL; Sciubba DM; Germscheid N; Goodwin CR; Wolinsky JP; Bettegowda C; Groves ML; Luzzati A; Rhines LD; Fisher CG; Varga PP; Dekutoski MB; Clarke MJ; Fehlings MG; Quraishi NA; Chou D; Reynolds JJ; Williams RP; Kawahara N; Boriani S
J Neurosurg Spine; 2016 Apr; 24(4):644-51. PubMed ID: 26682601
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Factors and Survival Outcome in Patients with Chordoma in the United States: A Population-Based Analysis.
Lee IJ; Lee RJ; Fahim DK
World Neurosurg; 2017 Aug; 104():346-355. PubMed ID: 28457925
[TBL] [Abstract][Full Text] [Related]
9. Outcomes and patterns of care in adult skull base chordomas from the Surveillance, Epidemiology, and End Results (SEER) database.
Jones PS; Aghi MK; Muzikansky A; Shih HA; Barker FG; Curry WT
J Clin Neurosci; 2014 Sep; 21(9):1490-6. PubMed ID: 24852903
[TBL] [Abstract][Full Text] [Related]
10. Association of cancer center type with treatment patterns and overall survival for patients with sacral and spinal chordomas: an analysis of the National Cancer Database from 2004 to 2015.
Wright CH; Wright J; Cioffi G; Hdeib A; Kasliwal MK; Kruchko C; Barnholtz-Sloan JS; Sloan AE
J Neurosurg Spine; 2019 Nov; 32(2):311-320. PubMed ID: 31675723
[TBL] [Abstract][Full Text] [Related]
11. Skull base chordoma and chondrosarcoma: influence of clinical and demographic factors on prognosis: a SEER analysis.
Bohman LE; Koch M; Bailey RL; Alonso-Basanta M; Lee JY
World Neurosurg; 2014 Nov; 82(5):806-14. PubMed ID: 25009165
[TBL] [Abstract][Full Text] [Related]
12. Disease outcomes for skull base and spinal chordomas: a single center experience.
Ahmed R; Sheybani A; Menezes AH; Buatti JM; Hitchon PW
Clin Neurol Neurosurg; 2015 Mar; 130():67-73. PubMed ID: 25590662
[TBL] [Abstract][Full Text] [Related]
13. Metastatic disease from spinal chordoma: a 10-year experience.
McPherson CM; Suki D; McCutcheon IE; Gokaslan ZL; Rhines LD; Mendel E
J Neurosurg Spine; 2006 Oct; 5(4):277-80. PubMed ID: 17048762
[TBL] [Abstract][Full Text] [Related]
14. Long-term clinical outcomes following en bloc resections for sacral chordomas and chondrosarcomas: a series of twenty consecutive patients.
Hsieh PC; Xu R; Sciubba DM; McGirt MJ; Nelson C; Witham TF; Wolinksy JP; Gokaslan ZL
Spine (Phila Pa 1976); 2009 Sep; 34(20):2233-9. PubMed ID: 19752710
[TBL] [Abstract][Full Text] [Related]
15. Pediatric Chordomas: A Population-Based Clinical Outcome Study Involving 86 Patients from the Surveillance, Epidemiology, and End Result (SEER) Database (1973-2011).
Lau CS; Mahendraraj K; Ward A; Chamberlain RS
Pediatr Neurosurg; 2016; 51(3):127-36. PubMed ID: 26881831
[TBL] [Abstract][Full Text] [Related]
16. Sacral Chordoma: A Population-based Analysis of Epidemiology and Survival Outcomes.
Scampa M; Tessitore E; Dominguez DE; Hannouche D; Buchs NC; Kalbermatten DF; Oranges CM
Anticancer Res; 2022 Feb; 42(2):929-937. PubMed ID: 35093892
[TBL] [Abstract][Full Text] [Related]
17. Preliminary results of high-dose single-fraction radiotherapy for the management of chordomas of the spine and sacrum.
Yamada Y; Laufer I; Cox BW; Lovelock DM; Maki RG; Zatcky JM; Boland PJ; Bilsky MH
Neurosurgery; 2013 Oct; 73(4):673-80; discussion 680. PubMed ID: 23842548
[TBL] [Abstract][Full Text] [Related]
18. Development of Machine Learning Algorithms for Prediction of 5-Year Spinal Chordoma Survival.
Karhade AV; Thio Q; Ogink P; Kim J; Lozano-Calderon S; Raskin K; Schwab JH
World Neurosurg; 2018 Nov; 119():e842-e847. PubMed ID: 30096498
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the Role of Adjuvant Radiotherapy in the Management of Sacral and Vertebral Chordoma: Results from a National Database.
Yolcu Y; Wahood W; Alvi MA; Kerezoudis P; Okuno SH; Foote RL; Bydon M
World Neurosurg; 2019 Jul; 127():e1137-e1144. PubMed ID: 30995559
[TBL] [Abstract][Full Text] [Related]
20. Long-term results: adjuvant radiotherapy in en bloc resection of sacrococcygeal chordoma is advisable.
Moojen WA; Vleggeert-Lankamp CL; Krol AD; Dijkstra SP
Spine (Phila Pa 1976); 2011 May; 36(10):E656-61. PubMed ID: 21217422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
